Hui Li

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Ri‐Yao Yang, Linlin Sun, Ching-Fei Li et al. · Nature Communications · 2021 · 605 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma

Yusheng Cheng, Hui Li, Yinan Deng et al. · Cell Death and Disease · 2018 · 394 citations · Full text

Life Sciences, Immunology, Oncology +17

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

Li-Chuan Chan, Chia‐Wei Li, Weiya Xia et al. · Journal of Clinical Investigation · 2019 · 383 citations · Full text

Medicine, Immunology, Oncology +17

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Xin Jin, Donglin Ding, Yuqian Yan et al. · Molecular Cell · 2018 · 270 citations · Full text

Medicine, Cancer Biology, Oncology +16

CD8+ IL-17-Producing T Cells Are Important in Effector Functions for the Elicitation of Contact Hypersensitivity Responses

Donggou He, Lizhi Wu, Hee Kyung Kim et al. · The Journal of Immunology · 2006 · 239 citations · Full text

Life Sciences, Immunology, Pathology +17